Dan A. Dixon is a Professor and Associate Director of Community Outreach and Engagement at the Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences (UAMS), where his research focuses on post-transcriptional gene regulation mechanisms in cancer pathogenesis. His academic credentials include: Ph.D. from Northwestern University B.A. from Augustana University Dr. Dixon's research centers on RNA-binding proteins (notably HuR and tristetraprolin) and their role in destabilizing oncogenic mRNA networks. His laboratory investigates how dysregulation of these post-transcriptional controllers permits overexpression of tumor-promoting genes involved in proliferation, angiogenesis, and metastasis. Key focus areas include colorectal cancer mechanisms, autophagy regulation via Rab27B, stress granule dynamics in mutant p53 contexts, and extracellular vesicle-mediated tumor microenvironment activation. Analysis of his 2022-2025 publications reveals intensifying work on XPO1 inhibition for colorectal cancer chemoprevention, Rab27B-autophagy axis characterization, and mutant p53 vulnerabilities. His studies consistently employ molecular techniques, mouse models (APC Min/+ ), and translational approaches to identify biomarkers and therapeutic targets. Dr. Dixon maintains active laboratory facilities at WPRCI 947 and 951, directing research that bridges fundamental RNA biology with clinical oncology applications. His leadership in community outreach complements his bench-to-bedside research philosophy.
Prof. Waldemar Kolanus leads the Molecular Immunology and Cell Biology department at the University of Bonn's Life & Medical Sciences Institute (LIMES) . His research bridges immunoregulation , stem cell dynamics , and metabolic stress responses in immune cells. Unit 2 member at LIMES Principal investigator in SFB 704 and ImmunoSensation Cluster Leads a multidisciplinary lab with postdocs, PhD students, and technical staff His work focuses on intracellular signaling pathways connecting immune activation to tissue homeostasis, particularly through: Cytohesin proteins in integrin-mediated adhesion and migration TRIM71 in stem cell regulation and congenital hydrocephalus High-salt environments affecting macrophage function Publication trends show expertise in immune cell migration , genetic models , and chemical inhibition , with frequent use of mice and zebrafish for in vivo studies. Key articles explore: TRIM71's dual role in auditory development and germ cell maintenance Cytohesin family's Golgi regulation and insulin signaling Ruxolitinib's off-target migration inhibition of dendritic cells Contact details: Address: LIMES Institute, Carl-Troll-Straße 31, Bonn Email: kolanus.sekretariat@uni-bonn.de Phone: +49 228 73-62788
Zhiling Gu is a Research Fellow at Yale School of Public Health, having earned her Ph.D. in Statistics at Iowa State University. Her work integrates statistical theory with applications in public health and medicine. Her research spans Functional Data Analysis Network Analysis Spatiotemporal Modeling Statistical AI Foundations Nonparametric Learning applied to neuroimaging, electronic health records, and environmental health studies. Recent publications focus on Adaptive spatiotemporal models Neuroimaging data processing Pandemic forecasting frameworks Environmental exposure modeling with methodological rigor and practical implementation. Scientific achievements include Runner-up in SMI 2023 Student Paper Competition She has taught STAT 305: Engineering Statistics (ISU) STAT 226: Business Statistics Statistical Computing Statistical Learning and actively engages in academic presentations at conferences like SMI 2024 and CMStatistics 2022.
Jessica Williams, PhD is an Assistant Professor in the Department of Neurosciences at the Cleveland Clinic Lerner Research Institute (LRI) with additional faculty appointments at Case Western Reserve University, Kent State University, and Cleveland State University. She serves as the Cleveland Clinic liaison for Kent State University and represents the Clinic on the Executive Council for the Brain Health Institute and the Biomedical Sciences Graduate Program Executive Committee. Education: Postdoctoral Fellowship in Neuroimmunology, Washington University School of Medicine (2017) Ph.D. in Immunology, The Ohio State University (2011) M.S. in Physiology, Purdue University (2006) B.S. in Biology/Chemistry, Lindenwood University (2004) Dr. Williams' research focuses on neuroimmune interactions during multiple sclerosis, particularly examining regional responses of CNS glia to immune stimuli and astrocyte-immune crosstalk. Her lab employs murine MS models, primary human and murine cell analyses, and MS patient lesion assessment to investigate cytokine-mediated neuroprotection and CNS repair mechanisms. Recent work highlights protective astrocyte functions mediated by traditionally deleterious cytokines. Analysis of her 15 most recent publications reveals consistent focus on neuroimmune crosstalk in MS, with increasing emphasis on astrocyte heterogeneity, cytokine signaling (particularly IFNγ), and novel therapeutic targets like immunoproteasomes. Key themes include regional CNS differences in immune responses, glial cell repair mechanisms, and translating basic findings into potential MS therapies. Scientific Awards: Lerner Research Institute Excellence in Education Award (2022) Mentor of the Year Award (2023) Dr. Williams actively mentors the next generation of scientists as evidenced by her CIMER Trained Mentor certification and the graduation of PhD student Brandon Smith. Her research is supported by significant funding from the NIH, National MS Society, W.M. Keck Foundation, Brain Health Research Institute, and Neurological and Vision Impact Area. She regularly serves on study sections for the NIH, National MS Society, and Department of Defense. The Williams Laboratory investigates the interplay between immune and central nervous systems during MS, with current projects examining cytokine-mediated neuroimmune crosstalk for CNS repair and regionally distinct glial responses to inflammation. The lab employs advanced techniques including murine MS models and primary human cell analyses to identify novel therapeutic pathways for MS patients.
Professor Guy Williams is a leading academic at the University of Cambridge with a focus on imaging science and clinical neurosciences, affiliated with Downing College and the Wolfson Brain Imaging Centre . Holding a PhD in Physics from his initial Natural Sciences degree, he specializes in nuclear magnetic resonance (NMR) and MRI techniques for brain imaging. Education: BA, PhD in Physics His research centers on non-invasive imaging of brain structure and function, particularly in traumatic brain injury (TBI) and dementia. His work involves developing novel MRI pulse sequences and advanced data analysis algorithms, including AI-based diagnostic tools. He leads studies on white matter integrity post-trauma, longitudinal dementia assessment, and applications of MRI in disorders of consciousness and addiction. Recent publications highlight collaborations in traumatic brain injury outcomes, AI-guided dementia prediction, and neuroimaging of post-COVID cognitive deficits. His team's work on ultra-high field laminar fMRI and distortion correction methods has advanced clinical neuroscience applications. Key techniques include diffusion tensor imaging (DTI), 7 Tesla MRI, and positron emission tomography (PET/MR). His research spans from basic NMR physics to clinical translation, with a strong emphasis on multi-site studies and real-world diagnostic implementation.
Professor Hala Zreiqat AM is a leading biomedical engineer at The University of Sydney , serving as the Director of the ARC Training Centre for Innovative BioEngineering . A Fellow of all major Australian academies (AAS, ATSE, FAHMS, FRSN), she develops 3D printed bioceramics for bone regeneration while championing diversity through initiatives like the IDEAL Society and BIOTech Futures mentorship program. Her work bridges academia, clinical practice, and industry in musculoskeletal research . Research Focus: Her lab creates synthetic bone scaffolds that mimic natural bone architecture, strength, and porosity, enabling non-rejected bone regeneration via patient-matched implants. Key applications include orthopaedic, dental, and maxillofacial repair , with over $18M in competitive funding and multiple patents. Current projects explore AI-driven scaffold performance prediction and anti-senescence strategies for aging-related bone loss. Scientific Trends: Recent publications highlight 3D printed nanovoxelated ceramics , antisenescence biomaterials , and multifunctional theranostic platforms . Her team integrates machine learning for scaffold design, atom probe tomography for interface analysis, and two-photon imaging for cellular monitoring in 3D environments. 2021-2022 Fulbright Senior Scholar 2018 NSW Premier's Woman of the Year 2019 Eureka Prize for Innovative Use of Technology Fellow of Australian Academy of Science (2021) Over $18M in research funding Teaching & Leadership: She designed core courses like Tissue Engineering and Nanomaterials in Medicine , mentoring 158 students in 2020 alone. As Chair of CAAR (2020-2023), she strengthens Australia-Arab collaborations. Her lab trains early-career researchers , with alumni now in academia and industry.
Angela Pitenis is an Associate Professor in the Department of Materials at the University of California, Santa Barbara (UCSB), within the College of Engineering. Her research focuses on interfacial phenomena in soft materials, particularly friction, adhesion, wear, and deformation of complex surfaces ranging from living cells to polymer nanocomposites. She employs advanced experimental techniques such as microscopy, spectroscopy, and interferometry to study these interfaces under extreme conditions and within buried environments. Her work has direct applications in healthcare, energy sustainability, and engineering design. Prof. Pitenis holds a Ph.D., M.Sc., and B.S. in Mechanical Engineering from the University of Florida. Her research group investigates biomaterials, hydrogel lubrication, and bioinspired materials, with recent studies addressing implant-associated inflammation, tumor cell dynamics in 3D microgels, and pH-responsive hydrogel friction. She is affiliated with the Materials Research Lab at UCSB and contributes to interdisciplinary projects at the intersection of materials science and biology. Notable research trends in her work include the development of biocompatible lubricious surfaces, understanding friction-induced biological responses, and designing smart materials with tunable mechanical properties. Her studies on photoresponsive hydrogels and superlubricious materials highlight innovations in responsive and adaptive material systems. Pitenis emphasizes in situ experimental methods and has pioneered techniques for analyzing dynamically evolving material interfaces. Her research also extends to marine biomaterials, such as the mechanical resilience of sessile tunicates, and explores applications in medical implants, bioreactors, and energy systems. While specific awards are not listed here, her contributions reflect a commitment to advancing soft matter tribology and biomaterials science.
Christopher E. Nelson is an Assistant Professor in the Department of Biomedical Engineering at the University of Arkansas, College of Engineering. His lab focuses on developing biologically inspired strategies for controlled drug and gene delivery, particularly in the context of gene therapy and regenerative medicine. He is actively supported by the NIH, DoD, and Arkansas Bioscience Institute. Education: Postdoctoral Fellow – Duke University Ph.D. – Vanderbilt University B.S. – University of Arkansas Research Focus: Dr. Nelson’s lab integrates genome editing technologies with targeted delivery systems to address challenges in treating genetic diseases and promoting tissue regeneration. Major themes include CRISPR/Cas9 delivery , gene regulation in wound healing , and safe-harbor genome integration in skeletal muscle. His work spans viral and non-viral delivery vehicles , including lipid nanoparticles and AAV vectors, with a strong emphasis on preclinical validation in models of Duchenne muscular dystrophy and inflammatory disease. Scientific Awards: Controlled Release Society Postdoctoral Fellowship The Hartwell Foundation Postdoctoral Fellowship NIH Pathway to Independence Award (K99/R00) Funding & Support: The Nelson Lab is currently funded by: NIH NIGMS R35 DoD CDMRP DMD IDEA Award Arkansas Bioscience Institute University of Arkansas Engineering & Honors Colleges Lab & Team: The Nelson Lab is a dynamic, interdisciplinary team working at the intersection of gene editing, biomaterials, and regenerative medicine. They regularly present at national conferences such as ASGCT and NCUR, and mentor undergraduate researchers through SURF and Honors College grants.
Senior Lecturer Outi Salo-Ahen is affiliated with Åbo Akademi University's Faculty of Natural Sciences and Engineering , Department of Pharmacy. Her research focuses on computational pharmacology, drug design, and pharmaceutical chemistry, particularly targeting chemokine receptors (CCR5/CXCR4) and transient receptor potential channels (TRPA1) for therapeutic applications. Doctor of Pharmacy (2006, University of Kuopio/UEF) MSc in Pharmaceutical Chemistry (2001, UEF) BSc in Pharmacy (1999, UEF) University Pedagogy Modules 1-5 (2012-2015) Her work contributes to UN Sustainable Development Goals through education and pharmaceutical innovation . Recent research trends include: Antimicrobial resistance solutions TRPA1 channel modulation Nanotechnology-enabled drug delivery Multi-target HIV-1 inhibitors 3D printing of biocompatible materials Computational analysis of nucleic acid frameworks She actively supervises doctoral projects, serves on assessment panels, and leads collaborations like Nordic Pharmaceutical Translation and Innovation. Her 60+ publications demonstrate expertise in molecular modeling and drug discovery.
Dr. Appala Raju Badireddy is an Associate Professor in the Department of Civil and Environmental Engineering at the University of Vermont (UVM), and Director of the Water Treatment & Environmental Nanotechnology (WTEN) Laboratory. He is also co-founder and CTO of Secure Surgical Solutions LLC, and a founding member of Vermont Initiative for Biological and Environmental Surveillance (VIBES). His research focuses on sustainable membrane processes, environmental nanotechnology, nanometrology, and water security. Education: Ph.D., Environmental Engineering, University of Houston (2003-2009) M.Tech., Chemical Engineering, Indian Institute of Technology Madras (2001-2003) B.Tech., Chemical Engineering, Jawaharlal Nehru Technological University Hyderabad (1997-2001) Postdoctoral Research, Duke University (2009-2014) under Prof. Mark Wiesner Research Interests: Sustainable Membrane Processes: Water/wastewater treatment, desalination, anti-fouling strategies, and resource recovery. Environmental Nanotechnology: Nano-enabled sensors, remediation, and implications of nanomaterials in ecosystems. Environmental Chemodynamics: PFAS fate/transport, nutrient cycling, and contaminant toxicity. Water Security: Real-time monitoring systems and soil health assessments. His work integrates lab-scale innovations with field applications, emphasizing interdisciplinary collaboration. Recent Research Trends: Recent publications highlight advancements in PFAS remediation, electric-field enhanced filtration, and living lab approaches to precision agriculture. He explores nanomaterials for water treatment while addressing their environmental implications through novel detection methods like ED-HSI microscopy. Labs & Initiatives: WTEN Lab: Focuses on nanotechnology-driven water solutions. VIBES: Develops environmental surveillance tools for public health. Secure Surgical Solutions: Applies nanotechnology to medical devices.
Preet Singh is a Professor and Associate Chair for Graduate Studies in the School of Materials Science and Engineering at Georgia Tech, with affiliations to the College of Engineering. His research focuses on corrosion science, electrochemistry, and environmental degradation of materials, particularly metals and alloys. Prior to joining Georgia Tech in 2003, he was a faculty member at the Institute of Paper Science and Technology (IPST), where he investigated corrosion issues in the pulp and paper industry. Professor Singh's work explores fundamental mechanisms of material degradation in industrial environments, aiming to develop mitigation strategies against environment-induced failures. Key research areas include corrosion fatigue, hydrogen embrittlement, stress corrosion cracking, and oxidation behavior. His group employs experimental approaches to study material reliability under varying chemical and mechanical conditions. Recent publications demonstrate interdisciplinary collaboration across oncology, agriculture, and energy systems, reflecting broad applications of materials science principles. Research trends show increased focus on biomedical materials and sustainable technologies alongside core corrosion studies. Professor Singh advises graduate students including Abdullah Alzubail, Yousif Al Rabie, Sai Shreeya, Yara, and Sean Li. He directs the Corrosion and Materials Reliability Laboratory (CMCRL), which partners with industry to solve practical engineering challenges related to material performance.
Matthias Barz is a Professor of Biotherapeutic Delivery at the Leiden Academic Centre for Drug Research (LACDR) , Faculty of Science , Leiden University . He leads the Barz Lab , focusing on polymer science and biomedical applications of functional nanoparticles. Professor of Biotherapeutic Delivery (Leiden University) Head of the Division of BioTherapeutics Researcher in reactive polymer systems and nanocarrier design His research bridges polymer chemistry with biomedical applications, emphasizing polypept(o)ide-based nanocarriers for targeted drug delivery in cancer, inflammation, and neurodegenerative diseases. Key areas include: Stimuli-responsive polymer architectures Secondary structure-driven self-assembly Core-crosslinked micelles for controlled cargo release Redox-sensitive disulfide bonds for intracellular delivery Protein-repellent nanoparticle shells Riboflavin-functionalized nanocarriers for tumor targeting The lab's publications highlight advancements in polysarcosine-containing copolymers , orthogonal functional group utilization , and modular nanoparticle platforms with precise control over morphology and function. Current projects explore the clinical translation of these systems for immunotherapy and diagnostics. Scientific recognition includes: Dozentenpreis des Fonds der Chemischen Industrie (2018) PMSE Young Investigator Award (2018) Nachwuchswissenschaftlerstipendium der GDCh (2017) His team trains graduate students in polymer synthesis, nanoparticle characterization, and biomedical application testing. Collaborations span institutions like the University of Tokyo and Johannes Gutenberg University Mainz , with ongoing projects under the SFB 1066 initiative for malignant melanoma immunotherapy.
Dr. Justin Belsky is an Assistant Professor of Emergency Medicine at Yale School of Medicine, serving as the COVID-19 Safety Officer and Co-Director of Resident Research in Emergency Medicine. He holds an MD from Wayne State University School of Medicine (2011) and an MPH from Harvard School of Public Health (2016). His research focuses on sepsis diagnosis and treatment, including biomarkers, clinical trials, and risk stratification tools. He led the Yale site for the VICTAS trial evaluating vitamin C, thiamine, and hydrocortisone in septic shock. Dr. Belsky directs the Yale Emergency Medicine Specimen Biobank, collecting samples from critically ill patients for future research. His awards include the Partners in Excellence Team Award (2016) and an Outstanding Poster Award (2015). He is actively involved in resident research training and clinical guideline adherence studies. Education: MD: Wayne State University School of Medicine (2011) Emergency Medicine Residency: Henry Ford Hospital (2014) Research Fellowship: Massachusetts General Hospital (2016) MPH: Harvard School of Public Health (2016) Research Interests: Early sepsis identification and treatment Biomarker development for critical illness Fluid management strategies in septic shock Micronutrient therapies in sepsis Emergency department quality improvement Recent Work Focus: Fluid resuscitation protocols and guideline adherence Long-term outcomes of sepsis therapies Actin cytoskeleton as a sepsis biomarker Antibiotic timing in sepsis Awards: 2016: Sepsis Care Redesign, Partners in Excellence Team Award 2015: Outstanding Poster Award (Shock Symposium) Grants & Mentorship: Principal investigator for CLOVERS trial (fluid management in sepsis) Co-Director of Yale’s Emergency Medicine Research Training Program Leadership in resident research mentorship and biobank initiatives
John C. Doyle is the Jean-Lou Chameau Professor of Control and Dynamical Systems, Electrical Engineering, and BioEngineering at the California Institute of Technology (Caltech), where he holds appointments in the Division of Engineering and Applied Science with primary affiliation in the Control and Dynamical Systems Department. His research bridges theoretical foundations with applications across biological, technological, medical, and ecological networks. He earned a BS and MS in Electrical Engineering from MIT (1977) and a PhD in Mathematics from UC Berkeley (1984), followed by consultancy at Honeywell Systems and Research Center (1976-1990). MIT: BS & MS in Electrical Engineering (1977) UC Berkeley: PhD in Mathematics (1984) Doyle's research centers on universal laws and architectures in complex systems, emphasizing robustness-efficiency tradeoffs, speed-accuracy tradeoffs (SATs), diversity-enabled sweet spots (DeSS), bowtie/hourglass structures, and evolvability. His work pioneers System Level Synthesis (SLS) for control systems with sparse, local, saturating, delayed, noisy, quantized, and distributed (SLSDNQD) components, integrating control theory, computation, communication, and machine learning to address challenges from neural networks to infrastructure resilience. Key concepts include virtualization, horizontal transfer, and virality in multiscale systems. Analysis of his publication trends reveals consistent interdisciplinary impact across neuroscience (brain connectivity modeling), systems biology (metabolic oscillations), network science (internet topology), and physics (turbulence, earthquakes), with recurring themes of robust-efficiency limits and architectural principles governing complex networks. His work demonstrates exceptional translation from abstract theory to practical tools like the Matlab Robust Control Toolbox and Systems Biology Markup Language (SBML). His scientific recognition includes: 1990 IEEE Baker Prize (ranked among top 10 most important mathematics papers 1981-1993) Three IEEE Automatic Control Transactions Awards (1998, 1999, 2021) ACM Sigcomm Paper Prize (2004) and Test of Time Award (2016) IEEE Control Systems Field Award (2004) Multiple early-career honors including IEEE Centennial Outstanding Young Engineer (1984) Doyle has mentored generations of students whose contributions include foundational software tools adopted globally. His research has secured sustained funding from NSF, NIH, and other agencies supporting theoretical advances in control frameworks and their applications to biomedical systems, network infrastructure, and environmental modeling. The SBML initiative exemplifies his group's impact in standardizing computational biology research. He leads a highly collaborative research ecosystem at Caltech that integrates engineers, biologists, neuroscientists, and computer scientists to develop universal principles for complex networks. Current efforts focus on translating theoretical insights into health technologies, resilient infrastructure, and climate-responsive systems through the application of robust-efficiency frameworks to emerging challenges in cyber-physical and biological domains.
Dr. Jeannine Baumgartner is a Lecturer in the Department of Nutritional Sciences at King's College London and an Extraordinary Associate Professor at North-West University, South Africa. She holds an MSc and PhD in Human Nutrition from ETH Zurich, Switzerland. Key Appointments : Lecturer at King's College London (2022–present), Senior Scientist at ETH Zurich (2018–2022), Associate Professor at North-West University (2018). Research Focus : Optimal early-life nutrition for maternal/child health, iron and omega-3 fatty acid interventions, stable isotope methodologies, HIV-metabolic interactions, and mental health-diet links. Her recent work explores iron absorption dynamics in Thai children, maternal iron status in South Africa, and omega-3 fatty acids in depression. She leads an NIHR-funded project to reassess UK iron reference values. Scientific Leadership : Board Member, International Society for the Study of Fatty Acids and Lipids (ISSFAL) Editorial Board, European Journal of Clinical Nutrition
